Detalhe da pesquisa
1.
Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics.
BMC Cancer
; 22(1): 732, 2022 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790916
2.
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data.
BMC Cancer
; 21(1): 977, 2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465283
3.
Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study).
BJU Int
; 126(5): 559-567, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654362
4.
Renal cell cancer metastases to esophagus and stomach successfully treated with radiotherapy and pazopanib.
Anticancer Drugs
; 26(1): 112-6, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25075797
5.
Controversies in the treatment of invasive urothelial carcinoma: a case report and review of the literature.
BMC Urol
; 15: 15, 2015 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25887442
6.
Difficulties on the access to innovative targeted therapies for lung cancer in Spain.
Clin Transl Oncol
; 26(3): 597-612, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37651020
7.
Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor Registry.
Clin Transl Oncol
; 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38862862
8.
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP.
Clin Transl Oncol
; 26(7): 1647-1663, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530556
9.
Sequential therapy in metastatic renal cell carcinoma: pre-clinical and clinical rationale for selecting a second- or subsequent-line therapy with a different mechanism of action.
Cancer Metastasis Rev
; 31 Suppl 1: S11-7, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22674353
10.
Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer.
Eur Respir J
; 51(5)2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29563169
11.
Screening for epidermal growth factor receptor mutations in lung cancer.
N Engl J Med
; 361(10): 958-67, 2009 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19692684
12.
Update from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma: focus on special populations.
Cancer Metastasis Rev
; 29 Suppl 1: 11-20, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20640588
13.
Updated recommendations from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma.
Cancer Metastasis Rev
; 29 Suppl 1: 1-10, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20640589
14.
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology.
Cancer Med
; 10(17): 5878-5888, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296539
15.
Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study.
Front Oncol
; 11: 695038, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34381717
16.
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
J Transl Med
; 8: 135, 2010 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21167064
17.
Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study.
BMC Psychol
; 8(1): 123, 2020 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33228796
18.
Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer.
J Clin Oncol
; 38(22): 2530-2542, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32459597
19.
Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.
Cancer Epidemiol
; 67: 101737, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32450544
20.
Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatin-based combinations in patients with small-cell lung cancer.
Lung Cancer
; 63(1): 83-7, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18555556